According to FutureWise analysis, the Dialysis Concentrates Market is estimated to be US$ 3.54 billion in 2025 and is expected to reach US$ 5.27 billion in 2033 at a CAGR of 5.1%. The market is experiencing growth due to the increasing global prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). Key factors contributing to this trend include innovations in bicarbonate-based concentrates and a greater adoption of home hemodialysis, both of which are leading to enhanced patient outcomes and a rising demand for treatment options.
Dialysis concentrates are the fluids consists of purified water, glucose and electrolytes. The concentration of electrolytes (besides potassium and the buffer substance) closely resembles that which occurs naturally in the blood. Dialysis fluid is prepared according to the individual patient’s needs to help regulate their electrolyte and acid–base balance and remove metabolic waste products. There are primarily two types of concentrates for haemodialysis: bicarbonate (base) and acid. Acid and bicarbonate are mixed with treated water which then forms the dialysis fluid (dialysate). Hemodialysate is the solute and fluid that flows through the dialyzer during the process of haemodialysis. Once the acid concentrate, water and bicarbonate concentrate are combined. The final dialysate can contain up to 3 buffer components. These components depend on the amount of acid concentrate used.
According to 10% of the world, population is affected by chronic kidney diseases and over 2 million people receive dialysis every year. Of this 2 million, 80% of the procedure is conducted in the US, Germany, Japan, Brazil and Italy and the rest of the world accounts 20% of the procedural volume. Because of this, there is a huge demand for dialysis in middle-income countries. Further, increasing prevalence of chronic kidney disorders led to the robust growth of the market. It is further augmented by increasing demand dialysis for effective management of kidney disorders boosted the adoption among end users. According to WHO, 2.6 million people received dialysis globally in 2010 and it is estimated that the number will be double by 2030. Further, the growing financial burden led to the development of effective treatment strategies focused toward better management. Dialysis is one such effective method for disease management over alternative treatment strategies.
Operational trends: focus on cost, storage footprint, and sustainability —Buyers are increasingly prioritizing products that minimize storage space, such as dry powders and concentrate mixing systems. They also favor solutions that lower shipping frequency and reduce waste. These features are particularly appealing to large dialysis chains and hospital networks that aim to cut operational costs and decrease their carbon footprint. This trend is evident in various capacity and product announcements.